Imaging-guided photothermal therapy (PTT) by combination of imaging and PTT has been emerging as a promising therapeutic method for precision therapy. However, the development of multicomponent nanoplatforms with stable structures for both PTT and multiple-model imaging remains a great challenge. Herein, we synthesized monodisperse Au-FeC Janus nanoparticles (JNPs) of 12 nm, which are multifunctional entities for cancer theranostics. Due to the broad absorption in the near-infrared range, Au-FeC JNPs showed a significant photothermal effect with a 30.2% calculated photothermal transduction efficiency under 808 nm laser irradiation in vitro. Owing to their excellent optical and magnetic properties, Au-FeC JNPs were demonstrated to be advantageous agents for triple-modal magnetic resonance imaging (MRI)/multispectral photoacoustic tomography (MSOT)/computed tomography (CT) both in vitro and in vivo. We found that Au-FeC JNPs conjugated with the affibody (Au-FeC-Z) have more accumulation and deeper penetration in tumor sites than nontargeting JNPs (Au-FeC-PEG) in vivo. Meanwhile, our results verified that Au-FeC-Z JNPs can selectively target tumor cells with low cytotoxicity and ablate tumor tissues effectively in a mouse model. In summary, monodisperse Au-FeC JNPs, used as a multifunctional nanoplatform, allow the combination of multiple-model imaging techniques and high therapeutic efficacy and have great potential for precision theranostic nanomedicines.

Magnetic nanomaterials (MNMs) have attracted significant interest in the past few decades because of their unique properties such as superparamagnetism, which results from the influence of thermal energy on a ferromagnetic nanoparticle. In the superparamagnetic size regime, the moments of nanoparticles fluctuate as a result of thermal energy. To understand the fundamental behavior of superparamagnetism and develop relevant potential applications, various preparation routes have been explored to produce MNMs with desired properties and structures. However, some challenges remain for the preparation of well-defined magnetic nanostructures, including exchange-coupled nanomagnets, which are considered as the next generation of advanced magnets. In such a case, effective synthetic methods are required to achieve control over the chemical composition, size, and structure of MNMs. For instance, liquid-phase chemical syntheses, a set of emerging approaches to prepare various magnetic nanostructures, facilitate precise control over the nucleation and specific growth processes of nanomaterials with diverse structures. Among them, the high-temperature organic-phase method is an indispensable one in which the microstructures and physical/chemical properties of MNMs can be tuned by controlling the reaction conditions such as precursor, surfactant, or solvent amounts, reaction temperature or time, reaction atmosphere, etc. In this Account, we present an overview of our progress on the chemical synthesis of various MNMs, including monocomponent nanostructures (e.g., metals, metal alloys, metal oxides/carbides) and multicomponent nanostructures (heterostructures and exchange-coupled nanomagnets). We emphasize the high-temperature organic-phase synthetic method, on which we have been focused over the past decade. Notably, multicomponent nanostructures, obtained by growing or incorporating different functional components together, not only retain the functionalities of each single component but also possess synergic properties that emerge from interfacial coupling, with improved magnetic, optical, or catalytic features. Herein, potential applications of MNMs are covered in three representative areas: biomedicine, catalysis, and environmental purification. Regarding biomedicine, MNMs can detect or target biological entities after being modified with specific biomolecules, and they can be applied to magnetic resonance imaging, imaging-guided drug delivery, and photothermal therapy. Apart from their magnetic features, the catalytic performance of some MNMs resulting from their highly specific chemical components and surface structure will be briefly introduced, highlighting its impact in the methanol oxidation reaction, the oxygen reduction reaction, the oxygen and hydrogen evolution reactions, and the Fischer-Tropsch synthesis. Finally, environmental purification, primarily for water remediation, will be highlighted with two main aspects: the effective capture of bacteria and the removal of adverse ions in wastewater. We hope that t...

Smart drug delivery systems (SDDSs) for cancer treatment are of considerable interest in the field of theranostics. However, developing SDDSs with early diagnostic capability, enhanced drug delivery and efficient biodegradability still remains a scientific challenge. Herein, we report near-infrared light and tumor microenvironment (TME), dual responsive as well as size-switchable nanocapsules. These nanocapsules are made of a PLGA-polymer matrix coated with Fe/FeO core-shell nanocrystals and co-loaded with chemotherapy drug and photothermal agent. Smartly engineered nanocapsules can not only shrink and decompose into small-sized nanodrugs upon drug release but also can regulate the TME to overproduce reactive oxygen species for enhanced synergistic therapy in tumors. In vivo experiments demonstrate that these nanocapsules can target to tumor sites through fluorescence/magnetic resonance imaging and offer remarkable therapeutic results. Our synthetic strategy provides a platform for next generation smart nanocapsules with enhanced permeability and retention effect, multimodal anticancer theranostics, and biodegradability.

Stimuli-controlled drug delivery and release is of great significance in cancer therapy, making a stimuli-responsive drug carrier highly demanded. Herein, a multistimuli-controlled drug carrier was developed by coating bovine serum albumin on Fe5C2 nanoparticles (NPs). With a high loading of the anticancer drug doxorubicin, the nanoplatform provides a burst drug release when exposed to near-infrared (NIR) light or acidic conditions. In vitro experiment demonstrated a NIR-regulated cell inhibition that is ascribed from cellular uptake of the carrier and the combination of photothermal therapy and enhanced drug release. The carrier is also magnetic-field-responsive, which enables targeted drug delivery under the guidance of a magnetic field and monitors the theranostic effect by magnetic resonance imaging. In vivo synergistic effect demonstrates that the magnetic-driven accumulation of NPs can induce a complete tumor inhibition without appreciable side effects to the treated mice by NIR irradiation, due to the combined photochemotherapy. Our results highlight the great potential of Fe5C2 NPs as a remote-controlled platform for photochemothermal cancer therapy.

Reactive oxygen species (ROS) are crucial molecules in cancer therapy. Unfortunately, the therapeutic efficiency of ROS is unsatisfactory in clinic, primarily due to their rigorous production conditions. By taking advantage of the intrinsic acidity and overproduction of H 2 O 2 in the tumor environment, we have reported an ROS nanoreactor based on core−shell-structured iron carbide (Fe 5 C 2 @Fe 3 O 4 ) nanoparticles (NPs) through the catalysis of the Fenton reaction. These NPs are able to release ferrous ions in acidic environments to disproportionate H 2 O 2 into • OH radicals, which effectively inhibits the proliferation of tumor cells both in vitro and in vivo. The high magnetization of Fe 5 C 2 @Fe 3 O 4 NPs is favorable for both magnetic targeting and T 2 -weighted magnetic resonance imaging (MRI). Ionization of these NPs simultaneously decreases the T 2 signal and enhances the T 1 signal in MRI, and this T 2 /T 1 switching process provides the visualization of ferrous ions release and ROS generation for the supervision of tumor curing. These Fe 5 C 2 @Fe 3 O 4 NPs show great potential in endogenous environment-excited cancer therapy with high efficiency and tumor specificity and can be guided further by MRI.